Objective: The cancer stem-like cells (CSC) CSC markers and the role derived from papillary thyroid carcinoma (PTC) in the pathogenesis is unclear. This study aims to determine the nature of CSC using a ball tumor cells passaged but without sorting PTC CSC.


Materials and Methods: To identify the properties of CSC derived from PTC, the expression of SRY-box transcription factor 2 (Sox2), octamer – bind transcription factor 4 (OCT 4 ), Nanog homeobox (NANOG), thyroglobulin (TG), thyroid-stimulating hormone receptor (TSHR), E-cadherin, YES-related protein 1 (YAP1), and signal transducer and activator transcription < / em> 3 (STAT3) was investigated in the field of serial tumor passaged without sorting CSC.


Results: Ball cultured tumor had cancer stemness; High expression of October 4 , Sox2, NANOG, and YAP1; Low expression of E-cadherin; and varied expression of TG, TSHR, and STAT3. PTC tumors ball transfected with small interfering RNA targeting YAP1 possess less of the ball CSC non-transfected tumors are doing.


Conclusions: Tumor sphere cells derived from PTC by passaging without sorting CSC has more stem cell-like properties, and less differentiation potential. Thus, a simple and cost-effective method can be used for enrichment PTC stemness to work in cell-based models, reducing the need for the use of animal models. Impact OCT4 and Its Related Signaling Pathways in Cancer Gastrointestinal: Focused on Targeted Therapies There are many pieces of evidence support the effects of cancer stem cells in the initiation and progression of cancer.

Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness
Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness

However, the related mechanisms involved in this phenomenon is much more complicated to understand. Stemness different functions factor in the cancer stem cells (CSC) and their complex associations at different levels of cancer have been reported. Therefore, it seems that the focus on a single master factor will be more helpful to solve the puzzle singling pathway in these cells. Octamer – bind transcription factor 4 (OCT 4 ) is also known as POU domain, class 5, transcription factor 1 (POU5F1), one of these pluripotency the factor , has an important role in both embryogenesis and tumorigenesis.

In this review, we collect information about the relationship of different markers to October 4 of expression in the three types of gastrointestinal cancers including esophageal, gastric and colorectal cancers. October 4 via different signaling pathways have an impact on different processes of gastrointestinal cancers such as proliferation, invasion, and metastasis. Based on the literature, Oct. 4 have a profound effect on the development of cancer at different stages, therefore we suggest it has potential implications in the choice of therapy.

Although the pharmacological action of cardiovascular Tanshinone IIA (TanIIA) have been extensively studied, research on the role in the regeneration of the heart is still sufficient. This study used H9c2 heart myoblast cell line to evaluate the possibility TanIIA role in cardiac regeneration. It was found that certain concentrations of TanIIA inhibited cell proliferation by suppressing the expression of proteins associated with cell cycle [cyclin dependent kinase (CDK) 4 , CDK6 and cyclin D1] and proliferation [c-Myc, octamer – bind transcription factor 4 (October 4 ) and growing multiply cell nuclear antigen (PCNA)] without inducing apoptosis.

Lin28 Antibody
25055-100ul 100ul
EUR 468

Lin28 Antibody
21426-100ul 100ul
EUR 302.4

Lin28 Antibody
21426-50ul 50ul
EUR 224.4

Lin28 antibody
3091-200 each
EUR 379.2

Lin28 antibody
3091-30T each
EUR 175.2

LIN28 Antibody
BF0638 200ul
EUR 540

Lin28 antibody
70R-11606 200 ug
EUR 483.6
Description: Rabbit polyclonal Lin28 antibody

Lin28 Antibody
5605-002mg 0.02 mg
EUR 206.18
Description: Lin28 Antibody: Lin28 is a transcription factor that was first identified through its key role in the pathway of developmental timing in C. elegans. The role of Lin28 in development suggested that it might be useful in the creation of stem cells that might be beneficial in cell replacement therapies in the treatment of several degenerative diseases. Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing Lin28 in addition to the transcription factors POU5F1, Sox2, and NANOG in mouse fibroblasts. More recently, experiments have demonstrated that iPS cells could be generated using expression plasmids expressing Lin28, Sox2, POU5F1 and c-Myc, eliminating the need for virus introduction, thereby addressing a safety concern for potential use of iPS cells in regenerative medicine.

Lin28 Antibody
5605-01mg 0.1 mg
EUR 523.7
Description: Lin28 Antibody: Lin28 is a transcription factor that was first identified through its key role in the pathway of developmental timing in C. elegans. The role of Lin28 in development suggested that it might be useful in the creation of stem cells that might be beneficial in cell replacement therapies in the treatment of several degenerative diseases. Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing Lin28 in addition to the transcription factors POU5F1, Sox2, and NANOG in mouse fibroblasts. More recently, experiments have demonstrated that iPS cells could be generated using expression plasmids expressing Lin28, Sox2, POU5F1 and c-Myc, eliminating the need for virus introduction, thereby addressing a safety concern for potential use of iPS cells in regenerative medicine.

Lin28 Antibody
49538-100ul 100ul
EUR 399.6

Lin28 Antibody
49538-50ul 50ul
EUR 286.8

LIN28 antibody
70R-18278 50 ul
EUR 522
Description: Rabbit polyclonal LIN28 antibody

LIN28 Antibody
F41528-0.08ML 0.08 ml
EUR 140.25
Description: Acts as a 'translational enhancer', driving specific mRNAs to polysomes and thus increasing the efficiency of protein synthesis. Its association with the translational machinery and target mRNAs results in an increased number of initiation events per molecule of mRNA and, indirectly, in stabilizing the mRNAs. Binds IGF2 mRNA, MYOD1 mRNA, ARBP/36B4 ribosomal protein mRNA and its own mRNA. Essential for skeletal muscle differentiation program through the translational up-regulation of IGF2 expression (By similarity). Acts as a suppressor of microRNA (miRNA) biogenesis by specifically binding the precursor let-7 (pre-let-7), a miRNA precursor. Acts by binding pre-let-7 and recruiting ZCCHC11/TUT4 uridylyltransferase, leading to the terminal uridylation of pre-let-7. Uridylated pre-let-7 miRNAs fail to be processed by Dicer and undergo degradation. Degradation of pre-let-7 in embryonic stem (ES) cells contributes to the maintenance of ES cells. In contrast, LIN28A down-regulation in neural stem cells by miR-125, allows the processing of pre-let-7. Specifically recognizes the 5'-GGAG-3' motif in the terminal loop of pre-let-7. Also recognizes and binds non pre-let-7 pre-miRNAs that contain the 5'-GGAG-3' motif in the terminal loop, leading to their terminal uridylation and subsequent degradation.

LIN28 Antibody
F41528-0.4ML 0.4 ml
EUR 322.15
Description: Acts as a 'translational enhancer', driving specific mRNAs to polysomes and thus increasing the efficiency of protein synthesis. Its association with the translational machinery and target mRNAs results in an increased number of initiation events per molecule of mRNA and, indirectly, in stabilizing the mRNAs. Binds IGF2 mRNA, MYOD1 mRNA, ARBP/36B4 ribosomal protein mRNA and its own mRNA. Essential for skeletal muscle differentiation program through the translational up-regulation of IGF2 expression (By similarity). Acts as a suppressor of microRNA (miRNA) biogenesis by specifically binding the precursor let-7 (pre-let-7), a miRNA precursor. Acts by binding pre-let-7 and recruiting ZCCHC11/TUT4 uridylyltransferase, leading to the terminal uridylation of pre-let-7. Uridylated pre-let-7 miRNAs fail to be processed by Dicer and undergo degradation. Degradation of pre-let-7 in embryonic stem (ES) cells contributes to the maintenance of ES cells. In contrast, LIN28A down-regulation in neural stem cells by miR-125, allows the processing of pre-let-7. Specifically recognizes the 5'-GGAG-3' motif in the terminal loop of pre-let-7. Also recognizes and binds non pre-let-7 pre-miRNAs that contain the 5'-GGAG-3' motif in the terminal loop, leading to their terminal uridylation and subsequent degradation.

LIN28 Antibody
E306153 100ug/200ul
EUR 275
Description: Available in various conjugation types.

LIN28 Antibody
E10-20271 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Lin28 Antibody
E021426 100μg/100μl
EUR 170
Description: Available in various conjugation types.

LIN28 Antibody
E2200808 100ug
EUR 255
Description: Available in various conjugation types.

Lin28 Antibody [1G9H9]
PM-6143-002mg 0.02 mg
EUR 206.18
Description: Lin28 Monoclonal Antibody: Lin28 is a transcription factor that was first identified through its key role in the pathway of developmental timing in C. elegans. The role of Lin28 in development suggested that it might be useful in the creation of stem cells that might be beneficial in cell replacement therapies in the treatment of several degenerative diseases. Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing Lin28 in addition to the transcription factors POU5F1, Sox2, and NANOG in mouse fibroblasts. More recently, experiments have demonstrated that iPS cells could be generated using expression plasmids expressing Lin28, Sox2, POU5F1 and c-Myc, eliminating the need for virus introduction, thereby addressing a safety concern for potential use of iPS cells in regenerative medicine.

Lin28 Antibody [1G9H9]
PM-6143-01mg 0.1 mg
EUR 523.7
Description: Lin28 Monoclonal Antibody: Lin28 is a transcription factor that was first identified through its key role in the pathway of developmental timing in C. elegans. The role of Lin28 in development suggested that it might be useful in the creation of stem cells that might be beneficial in cell replacement therapies in the treatment of several degenerative diseases. Artificial stem cells, termed induced pluripotent stem (iPS) cells, can be created by expressing Lin28 in addition to the transcription factors POU5F1, Sox2, and NANOG in mouse fibroblasts. More recently, experiments have demonstrated that iPS cells could be generated using expression plasmids expressing Lin28, Sox2, POU5F1 and c-Myc, eliminating the need for virus introduction, thereby addressing a safety concern for potential use of iPS cells in regenerative medicine.

LIN28 (pS134) Antibody
abx032091-400ul 400 ul
EUR 627.6

LIN28 (pS134) Antibody
abx032091-80l 80 µl
EUR 343.2

Polyclonal Lin28 Antibody
AMM06296G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Lin28 . This antibody is tested and proven to work in the following applications:

Polyclonal LIN28 Antibody
AMM06297G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIN28 . This antibody is tested and proven to work in the following applications:

Lin28 Conjugated Antibody
C49538 100ul
EUR 476.4

Lin28 Conjugated Antibody
C21426 100ul
EUR 476.4

LIN28 Polyclonal Antibody
E96034 100ul
EUR 225
Description: Available in various conjugation types.

LIN28 Antibody (phospho-S134)
F48636-0.08ML 0.08 ml
EUR 140.25
Description: LIN28 is probable transcription factor. It plays a critical role in the control of immune response.

LIN37 Antibody (FITC)
20-abx309143
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Monoclonal LIN28 Antibody, Clone: 6D1F9
AMM02686G 0.1ml
EUR 633.6
Description: A Monoclonal antibody against Human LIN28. The antibodies are raised in Mouse and are from clone 6D1F9. This antibody is applicable in WB, ICC, E

Anti-LIN28 antibody
PAab04783 100 ug
EUR 426

LIN37 Antibody, FITC conjugated
1-CSB-PA836222LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LIN37. Recognizes LIN37 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Polyclonal LIN28A / LIN28 Antibody (C-Terminus)
AMM06299G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIN28A / LIN28 (C-Terminus). This antibody is tested and proven to work in the following applications:

LIN9 Antibody, FITC conjugated
1-CSB-PA716370LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LIN9. Recognizes LIN9 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

LIN28A Antibody, FITC conjugated
1-CSB-PA13619C0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LIN28A. Recognizes LIN28A from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

LIN28B Antibody, FITC conjugated
1-CSB-PA741049LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LIN28B. Recognizes LIN28B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Monoclonal Lin28 Antibody [1G9H9] , Clone: 1G9H9
AMM06298G 0.1 mg
EUR 790.8
Description: A Monoclonal antibody against Human Lin28 [1G9H9] . The antibodies are raised in Mouse and are from clone 1G9H9. This antibody is applicable in WB, E

Protein Lin-28 Homolog A (LIN28) Antibody
abx234783-100ug 100 ug
EUR 577.2

Protein Lin-28 Homolog A (LIN28) Antibody
abx026317-400ul 400 ul
EUR 627.6

Protein Lin-28 Homolog A (LIN28) Antibody
abx026317-80l 80 µl
EUR 343.2

Protein Lin-28 Homolog A (LIN28) Antibody
abx036687-100ug 100 ug
EUR 469.2

Protein Lin-28 Homolog A (LIN28) Antibody
abx011091-100ul 100 ul
EUR 493.2

LIN7A Antibody, FITC conjugated
1-CSB-PA012963LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LIN7A. Recognizes LIN7A from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

LINC00846 Antibody (FITC)
20-abx311644
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

LINC00299 Antibody (FITC)
20-abx314552
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

LINC01553 Antibody (FITC)
20-abx303234
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Noelin Antibody FITC Antibody FITC
STJ501939 100 µg
EUR 703.2

Anti-Noelin Antibody FITC Antibody FITC
STJ501941 100 µg
EUR 703.2

Anti-LIN28 Monoclonal Antibody
M01966-1 100ug
EUR 476.4
Description: Rabbit Monoclonal LIN28 Antibody. Validated in IP, IF, WB and tested in Human.

Lin-28 Homolog B (LIN28B) Antibody (FITC)
20-abx315062
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Lin-28 Homolog A (LIN28A) Antibody (FITC)
20-abx337280
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

LIN37 Polyclonal Antibody, FITC Conjugated
A59632
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Anti-CCK-BR antibody
STJ92073 200 µl
EUR 236.4
Description: Rabbit polyclonal to CCK-BR.

LIN7A Polyclonal Antibody, FITC Conjugated
A62876
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Protein Lin-7 Homolog A (LIN7A) Antibody (FITC)
20-abx304363
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Lin28 Antibody [JA10-63]
ET1704-26 100ul
EUR 231
Description: LIN-28 is a highly conserved, RNA-binding, cytoplasmic protein. It consists of a cold shock domain and retroviral-type (CCHC) zinc finger motifs that were first identified in Caenorhabditis elegans. LIN-28 controls the timing of events during embryonic development and is readily expressed in embryos, embryonic stem cells and embryonal carcinoma cells. The presence of LIN-28 persists in some adult tissues including cardiac and skeletal muscle. In differentiating myoblasts, LIN-28 increases protein sysnthesis efficiency and binds to the growth and differentiation factor IGF-II.

Lin28
E8ET1704-26 100ul
EUR 275
Description: Available in various conjugation types.

LIN28
pro-743 2µg
EUR 60
Description: Recombinant Human LIN28

Human LIN7C AssayLite Antibody (FITC Conjugate)
33386-05141 150 ug
EUR 513.6

LINC00846 Antibody, FITC conjugated
1-CSB-PA882112LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LINC00846. Recognizes LINC00846 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

LINC00299 Antibody, FITC conjugated
1-CSB-PA765077LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LINC00299. Recognizes LINC00299 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

LINC01553 Antibody, FITC conjugated
1-CSB-PA002950LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LINC01553. Recognizes LINC01553 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Anti-Lin28 Rabbit Monoclonal Antibody
M01966 100ug/vial
EUR 476.4
Description: Rabbit Monoclonal Lin28 Antibody. Validated in IP, WB and tested in Human.

Anti-B19 Antibody FITC
STJ501376 100 µg
EUR 703.2

Anti-Brk Antibody FITC
STJ502713 100 µg
EUR 703.2

Anti-BLK Antibody (FITC)
STJ500260 100 µg
EUR 703.2

Anti-BTK Antibody (FITC)
STJ500305 100 µg
EUR 703.2

Anti-MB Antibody (FITC)
STJ501833 100 µg
EUR 703.2

Anti-BCL6 Antibody (FITC)
STJ500222 100 µg
EUR 703.2

Anti-BCL6 Antibody (FITC)
STJ500225 100 µg
EUR 703.2

Anti-BCL6 Antibody (FITC)
STJ500228 100 µg
EUR 703.2

Anti-BCL6 Antibody (FITC)
STJ500230 100 µg
EUR 703.2

Anti-BMP1 Antibody (FITC)
STJ500267 100 µg
EUR 703.2

Anti-BMP1 Antibody (FITC)
STJ500269 100 µg
EUR 703.2

Anti-BMP2 Antibody FITC
STJ500274 100 µg
EUR 703.2

Anti-BMP4 Antibody FITC
STJ500276 100 µg
EUR 703.2

Anti-BRAF Antibody (FITC)
STJ500284 100 µg
EUR 703.2

Anti-BST1 Antibody (FITC)
STJ500287 100 µg
EUR 703.2

Anti-BST2 Antibody (FITC)
STJ500292 100 µg
EUR 703.2

Anti-BST2 Antibody (FITC)
STJ500294 100 µg
EUR 703.2

Anti-BST2 Antibody (FITC)
STJ500296 100 µg
EUR 703.2

Anti-PGR Antibody (FITC)
STJ502477 100 µg
EUR 703.2

Anti-PGR Antibody (FITC)
STJ502479 100 µg
EUR 703.2

Anti-PRL Antibody (FITC)
STJ502657 100 µg
EUR 703.2

Anti-PRL Antibody (FITC)
STJ502659 100 µg
EUR 703.2

Anti-VHL Antibody (FITC)
STJ502737 100 µg
EUR 703.2

Anti-SFN Antibody (FITC)
STJ502962 100 µg
EUR 703.2

Anti-SHC Antibody FITC
STJ503001 100 µg
EUR 703.2

Anti-SYK Antibody (FITC)
STJ503184 100 µg
EUR 703.2

Anti-SYP Antibody (FITC)
STJ503188 100 µg
EUR 703.2

Anti-SYP Antibody (FITC)
STJ503190 100 µg
EUR 703.2

Anti-SRC Antibody (FITC)
STJ503203 100 µg
EUR 703.2

Anti-SRC Antibody (FITC)
STJ503205 100 µg
EUR 703.2

Anti-TEK Antibody (FITC)
STJ503260 100 µg
EUR 703.2

Anti-TEK Antibody (FITC)
STJ503262 100 µg
EUR 703.2

Anti-trp Antibody FITC
STJ503410 100 µg
EUR 703.2

Anti-AFP Antibody (FITC)
STJ500053 100 µg
EUR 703.2

Anti-AGE Antibody FITC
STJ500056 100 µg
EUR 703.2

Anti-AQR Antibody (FITC)
STJ500152 100 µg
EUR 703.2

Anti-Axl Antibody FITC
STJ500200 100 µg
EUR 703.2

Anti-C4A Antibody (FITC)
STJ500329 100 µg
EUR 703.2

Anti-CD2 Antibody (FITC)
STJ500438 100 µg
EUR 703.2

Anti-CD2 Antibody (FITC)
STJ500440 100 µg
EUR 703.2

Anti-CR2 Antibody (FITC)
STJ500444 100 µg
EUR 703.2

Anti-CR2 Antibody (FITC)
STJ500446 100 µg
EUR 703.2

Anti-CD4 Antibody (FITC)
STJ500471 100 µg
EUR 703.2

Anti-CD4 Antibody (FITC)
STJ500473 100 µg
EUR 703.2

Anti-KIT Antibody (FITC)
STJ500566 100 µg
EUR 703.2

Anti-KIT Antibody (FITC)
STJ500569 100 µg
EUR 703.2

Anti-KIT Antibody (FITC)
STJ500571 100 µg
EUR 703.2

Anti-KIT Antibody (FITC)
STJ500573 100 µg
EUR 703.2

Anti-KIT Antibody (FITC)
STJ500575 100 µg
EUR 703.2

Anti-MYC Antibody (FITC)
STJ500594 100 µg
EUR 703.2

Anti-MYC Antibody (FITC)
STJ500596 100 µg
EUR 703.2

Anti-DCC Antibody (FITC)
STJ500740 100 µg
EUR 703.2

Anti-DCK Antibody FITC
STJ500743 100 µg
EUR 703.2

Anti-DEK Antibody (FITC)
STJ500752 100 µg
EUR 703.2

Anti-ERG Antibody (FITC)
STJ500951 100 µg
EUR 703.2

Anti-ERG Antibody (FITC)
STJ500953 100 µg
EUR 703.2

Anti-FGR Antibody (FITC)
STJ501048 100 µg
EUR 703.2

Anti-FSH Antibody FITC
STJ501090 100 µg
EUR 703.2

Anti-FYN Antibody (FITC)
STJ501111 100 µg
EUR 703.2

Anti-GFP Antibody FITC
STJ501150 100 µg
EUR 703.2

Anti-GBA Antibody (FITC)
STJ501180 100 µg
EUR 703.2

Anti-LTF Antibody (FITC)
STJ501355 100 µg
EUR 703.2

Anti-LTF Antibody (FITC)
STJ501357 100 µg
EUR 703.2

Anti-ILK Antibody (FITC)
STJ501451 100 µg
EUR 703.2

Anti-ITK Antibody (FITC)
STJ501511 100 µg
EUR 703.2

Anti-LCT Antibody FITC
STJ501566 100 µg
EUR 703.2

Anti-LAT Antibody (FITC)
STJ501581 100 µg
EUR 703.2

Anti-LCK Antibody (FITC)
STJ501587 100 µg
EUR 703.2

Anti-LYN Antibody (FITC)
STJ501641 100 µg
EUR 703.2

Anti-MPO Antibody (FITC)
STJ501783 100 µg
EUR 703.2

Anti-MPO Antibody (FITC)
STJ501785 100 µg
EUR 703.2

Anti-MPO Antibody (FITC)
STJ501787 100 µg
EUR 703.2

Anti-MPO Antibody (FITC)
STJ501789 100 µg
EUR 703.2

Anti-MPO Antibody (FITC)
STJ501791 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501902 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501904 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501906 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501908 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501910 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501912 100 µg
EUR 703.2

Anti-MME Antibody (FITC)
STJ501914 100 µg
EUR 703.2

Anti-OGT Antibody (FITC)
STJ502001 100 µg
EUR 703.2

Anti-CD3 antibody (FITC)
STJ97919 100 µl
EUR 280.8
Description: Mouse monoclonal to CD3 (FITC).

Anti-CD4 antibody (FITC)
STJ97927 100 µl
EUR 280.8
Description: Mouse monoclonal to CD4 (FITC).

Anti-CD8 antibody (FITC)
STJ97937 100 µl
EUR 280.8
Description: Mouse monoclonal to CD8 (FITC).

Anti-5HT1A Antibody FITC
STJ500002 100 µg
EUR 703.2

Anti-5HT1B Antibody FITC
STJ500005 100 µg
EUR 703.2

Anti-BIRC5 Antibody (FITC)
STJ503166 100 µg
EUR 703.2

Anti-BACE2 Antibody (FITC)
STJ500210 100 µg
EUR 703.2

Anti-BACE2 Antibody (FITC)
STJ500212 100 µg
EUR 703.2

Anti-BCKDK Antibody (FITC)
STJ500215 100 µg
EUR 703.2

Anti-BEST1 Antibody (FITC)
STJ500240 100 µg
EUR 703.2

Anti-BEST1 Antibody (FITC)
STJ500242 100 µg
EUR 703.2

Anti-BEST1 Antibody (FITC)
STJ500244 100 µg
EUR 703.2

Anti-BEST3 Antibody (FITC)
STJ500250 100 µg
EUR 703.2

Anti-BEST4 Antibody (FITC)
STJ500252 100 µg
EUR 703.2

Anti-BEST4 Antibody (FITC)
STJ500254 100 µg
EUR 703.2

Anti-BMP8B Antibody (FITC)
STJ500278 100 µg
EUR 703.2

In this process, the expression of cardiac troponin in the treated cells was significantly increased and the migration of cells to the wound area to be treated is significantly improved.